Jornay PM

Generic name: Methylphenidate Hydrochloride
Dosage form: oral extended-release capsule
Drug class: CNS stimulants

Usage of Jornay PM

Jornay PM is a once-a-day capsule used to treat attention deficit hyperactivity disorder (ADHD). It contains a central nervous system (CNS) stimulant called methylphenidate hydrochloride.

It's not known exactly how Jornay PM works in people with ADHD, but it is a stimulant that increases activity in the brain, especially in the areas that help regulate behavior and attention. It helps to boost the levels of dopamine and noradrenaline, which are chemical messengers (neurotransmitters), by preventing their re-uptake from the space between nerve cells (neurons) in the brain. Low levels of these chemical messengers have been found in people with ADHD.

Jornay PM is taken in the evening. Each capsule contains two layers. The outside layer is designed to delay the release of the drug so that it doesn't start to be released until about 12 hours after it is taken. The inside layer extends the amount of time the drug is released into your body for. The two-layer approach is designed to help ensure Jornay PM is working when you wake up and keeps working during the day.

Medications containing methylphenidate, such as Jornay PM, are schedule II federally controlled substances because they can be a target for people who abuse prescription medicines or street drugs. Selling or giving away Jornay PM may harm others, and is against the law.

Jornay PM was approved for use by the US Food and Drug Administration (FDA) in 2018, although methylphenidate in another formulation was first approved many years earlier in 1955.

Jornay PM side effects

Jornay PM can cause serious side effects, including:

  • See "Important information" above.
  • Painful and prolonged erections (priapism). Priapism has happened in males who take products that contain methylphenidate. If you or your child develops priapism, get medical help right away.
  • Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud's phenomenon). Signs and symptoms may include:
  • fingers or toes may feel numb, cool, or painful
  • fingers or toes may change color from pale, to blue, to red Tell your healthcare provider if you or your child has numbness, pain, skin color change, or sensitivity to temperature in the fingers or toes. Call your healthcare provider right away if you or your child has any signs of unexplained wounds appearing on fingers or toes during treatment with this medication.
  • Slowing of growth (height and weight) in children. Children should have their height and weight checked often during treatment. Treatment may be stopped if your child is not gaining weight or height.

    • The most common side effects of methylphenidate products in children, adolescents, and adults with ADHD include:

  • decreased appetite
  • trouble sleeping
  • nausea
  • vomiting
  • indigestion
  • stomach pain
  • weight loss
  • anxiety
  • dizziness
  • irritability
  • mood swings (affect liability)
  • increased heart rate
  • increased blood pressure

    • The most common side effects of Jornay PM, in children age 6 to 12 with ADHD include:

  • trouble sleeping
  • decreased appetite
  • restlessness (psychomotor hyperactivity)
  • headache
  • nausea
  • mood swings
  • vomiting

    • These are not all the possible side effects of this medication.

    Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Jornay PM

    Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known whether Jornay PM will harm your unborn baby.

    There is a pregnancy registry for females who are exposed to this medication during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Jornay PM and their baby. If you or your child becomes pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychostimulants. You can register by calling 1-866-961-2388.

    Tell your healthcare provider if you are breastfeeding or plan to breastfeed. Jornay PM passes into breast milk. Talk to your healthcare provider about the best way to feed the baby during treatment with this medication.

    Relate drugs

    How to use Jornay PM

    The recommended starting dose of Jornay PM for patients 6 years and over is 20 mg daily in the evening. The dose may be increased weekly in increments of 20 mg up to a maximum daily dose of 100 mg. Jornay PM should be taken between 6:30 pm and 9:30 pm. The timing of the dose can be adjusted within this window to help reduce side effects and ensure it is working when needed the following day.

    See the Full Prescribing Information for further details about Jornay PM dosing.

    Warnings

    Jornay PM can cause serious side effects, including:

  • Abuse and Dependence. This medication contains methylphenidate. Jornay PM, other methylphenidate containing products, and amphetamines, have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with this medication.
  • Tell your healthcare provider if you or your child has ever abused or been dependent on alcohol, prescription medicines, or street drugs.
  • Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.
  • Heart-related problems, including:
  • sudden death, stroke, and heart attack in adults
  • sudden death in children who have heart problems or heart defects
  • increased blood pressure and heart rate Your healthcare provider should check you or your child carefully for heart problems before starting this medication. Tell your healthcare provider if you or your child has any heart problems, heart defects, or high blood pressure. Your healthcare provider should check you or your child's blood pressure and heart rate regularly during treatment with this medication. Call your healthcare provider right away or go to the nearest hospital emergency room right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting during treatment.
  • Mental (psyChiatric) problems, including:
  • new or worse behavior and thought problems
  • new or worse bipolar illness
  • new psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms Tell your healthcare provider about any mental problems you or your child has, or about a family history of suicide, bipolar illness, or depression. Call your healthcare provider right away if you or your child have any new or worsening mental symptoms or problems during treatment, especially hearing voices, seeing or believing things that are not real, or new manic symptoms.

    • What other drugs will affect Jornay PM

    Tell your healthcare provider about all of the medicines that you or your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    Jornay PM and some medicines may interact with each other and cause serious side effects. Sometimes the doses of other medicines will need to be adjusted during treatment.

    Your healthcare provider will decide whether Jornay PM can be taken with other medicines.

    Especially tell your healthcare provider if you or your child takes medicine to treat depression, including MAOIs.

    Know the medicines that you or your child takes. Keep a list of the medicines with you to show your healthcare provider and pharmacist when you or your child get a new medicine.

    Do not start any new medicine during treatment without talking to your or your child's healthcare provider first.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords